iPHARMA OZEMPIC / SEMAGLUTIDE PEN
Once-Weekly GLP-1 Therapy for Weight Loss and Blood Sugar Control
Ozempic® is a once-weekly injectable medication containing Semaglutide, a clinically proven GLP-1 receptor agonist originally developed to help manage type 2 diabetes. It works by mimicking the natural GLP-1 hormone, which regulates appetite, slows digestion, and helps control blood sugar levels — making it highly effective for both weight loss and metabolic balance.
How It Works
Semaglutide acts on GLP-1 receptors in the body to:
Reduce hunger and calorie intake
Slow gastric emptying to increase fullness
Stimulate insulin secretion when blood sugar is high
Lower glucose production by the liver
This combination of effects helps promote steady, sustainable weight loss while improving overall metabolic health.
Product Description
Form: Prefilled, single-use pen containing a clear liquid solution
Active Ingredient: Semaglutide
Administration: Subcutaneous injection (under the skin)
Recommended injection sites:
Abdomen (stomach area)
Upper thigh
Back of upper arm
If you also inject insulin, you may use the same body region — but never the same injection spot — to prevent irritation.
Do not mix Ozempic with insulin in the same syringe.
Usage Instructions
Inject once weekly, on the same day each week
Can be taken any time of day, with or without food
Rotate injection sites each week to avoid skin irritation
Dosage Guide
10 Units = 0.125mg Semaglutide
Week
Dose (mg)
Units
Notes
1
0.25mg
20 units
Initiation phase
2
0.50mg
40 units
Titration
3
0.50mg
40 units
Continue dose
4
0.50mg
40 units
Maintain tolerance
5
0.75mg
60 units
Begin stronger response
6+
0.75–1.0mg
60–80 units
Ongoing maintenance
Increase dosage gradually to minimize nausea or digestive discomfort.